Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Association of Serum Potassium with All-Cause Mortality in Patients with and without Heart Failure, Chronic Kidney Disease, and/or Diabetes
Allan J. Collins, Bertram Pitt, Nancy L. Reaven, et al.
American Journal of Nephrology (2017) Vol. 46, Iss. 3, pp. 213-221
Open Access | Times Cited: 332

Showing 1-25 of 332 citing articles:

KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease
Paul E. Stevens, Sofia B. Ahmed, Juan Jesús Carrero, et al.
Kidney International (2024) Vol. 105, Iss. 4, pp. S117-S314
Open Access | Times Cited: 1997
Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies: A Scientific Statement From the American Heart Association
Janani Rangaswami, Vivek Bhalla, John E. Blair, et al.
Circulation (2019) Vol. 139, Iss. 16
Open Access | Times Cited: 926
Iron management in chronic kidney disease: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference
Iain C. Macdougall, Andreas J. Bircher, Kai‐Uwe Eckardt, et al.
Kidney International (2016) Vol. 89, Iss. 1, pp. 28-39
Open Access | Times Cited: 442
Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Catherine M. Clase, Juan Jesús Carrero, David H. Ellison, et al.
Kidney International (2019) Vol. 97, Iss. 1, pp. 42-61
Open Access | Times Cited: 371
Potassium Intake and Blood Pressure: A Dose‐Response Meta‐Analysis of Randomized Controlled Trials
Tommaso Filippini, Androniki Naska, Maria‐Iosifina Kasdagli, et al.
Journal of the American Heart Association (2020) Vol. 9, Iss. 12
Open Access | Times Cited: 193
Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial
George L. Bakris, Rajiv Agarwal, Stefan D. Anker, et al.
American Journal of Nephrology (2019) Vol. 50, Iss. 5, pp. 333-344
Open Access | Times Cited: 160
Clinical Management of Hyperkalemia
Biff F. Palmer, Juan Jesús Carrero, Deborah J. Clegg, et al.
Mayo Clinic Proceedings (2020) Vol. 96, Iss. 3, pp. 744-762
Open Access | Times Cited: 144
2022 Guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the Management of Hypertension.
Tzung‐Dau Wang, Chern‐En Chiang, Ting‐Hsing Chao, et al.
PubMed (2022) Vol. 38, Iss. 3, pp. 225-325
Closed Access | Times Cited: 90
Abnormalities of Potassium in Heart Failure
João Pedro Ferreira, Javed Butler, Patrick Rossignol, et al.
Journal of the American College of Cardiology (2020) Vol. 75, Iss. 22, pp. 2836-2850
Open Access | Times Cited: 128
Management of hyperkalemia in the acutely ill patient
François Dépret, W. Frank Peacock, Kathleen D. Liu, et al.
Annals of Intensive Care (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 112
Hypokalemia-Induced Arrhythmias and Heart Failure: New Insights and Implications for Therapy
Jonas Skogestad, Jan Magnus Aronsen
Frontiers in Physiology (2018) Vol. 9
Open Access | Times Cited: 107
Management of hyperkalemia in patients with kidney disease: a position paper endorsed by the Italian Society of Nephrology
Stefano Bianchi, Filippo Aucella, Luca De Nicola, et al.
Journal of Nephrology (2019) Vol. 32, Iss. 4, pp. 499-516
Open Access | Times Cited: 95
Effect of KBP-5074 on Blood Pressure in Advanced Chronic Kidney Disease: Results of the BLOCK-CKD Study
George L. Bakris, Pablo E. Pérgola, Belkis Delgado, et al.
Hypertension (2021) Vol. 78, Iss. 1, pp. 74-81
Open Access | Times Cited: 94
Potassium Binders for Hyperkalemia in Chronic Kidney Disease—Diet, Renin-Angiotensin-Aldosterone System Inhibitor Therapy, and Hemodialysis
Biff F. Palmer
Mayo Clinic Proceedings (2019) Vol. 95, Iss. 2, pp. 339-354
Open Access | Times Cited: 92
Does dietary potassium intake associate with hyperkalemia in patients with chronic kidney disease?
Christiane Ishikawa Ramos, Ailema González-Ortíz, Ángeles Espinosa-Cuevas, et al.
Nephrology Dialysis Transplantation (2020) Vol. 36, Iss. 11, pp. 2049-2057
Closed Access | Times Cited: 92
Posaconazole Serum Drug Levels Associated With Pseudohyperaldosteronism
Minh-Vu H Nguyen, Matthew R Davis, Rebecca Wittenberg, et al.
Clinical Infectious Diseases (2019) Vol. 70, Iss. 12, pp. 2593-2598
Open Access | Times Cited: 89
Biomarkers to Guide Medical Therapy in Primary Aldosteronism
Gregory L. Hundemer, Alexander A. C. Leung, Gregory Kline, et al.
Endocrine Reviews (2023) Vol. 45, Iss. 1, pp. 69-94
Open Access | Times Cited: 29
Clinical impact of suboptimal RAASi therapy following an episode of hyperkalemia
Eiichiro Kanda, Anjay Rastogi, Toyoaki Murohara, et al.
BMC Nephrology (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 24
Comorbidity of patients with noncommunicable diseases in general practice. Eurasian guidelines
О. М. Драпкина, А. V. Kontsevaya, А. М. Калинина, et al.
CARDIOVASCULAR THERAPY AND PREVENTION (2024) Vol. 23, Iss. 3, pp. 3696-3696
Open Access | Times Cited: 16
JCS/JHFS 2025 Guideline on Diagnosis and Treatment of Heart Failure
Takeshi Kitai, Shun Kohsaka, Takao Kato, et al.
Journal of Cardiac Failure (2025)
Closed Access | Times Cited: 1
Association of Abnormal Serum Potassium Levels with Arrhythmias and Cardiovascular Mortality: a Systematic Review and Meta-Analysis of Observational Studies
Liesa Katharina Hoppe, Dana Clarissa Muhlack, Wolfgang Köenig, et al.
Cardiovascular Drugs and Therapy (2018) Vol. 32, Iss. 2, pp. 197-212
Closed Access | Times Cited: 74
Serum potassium and clinical outcomes in heart failure patients: results of risk calculations in 21 334 patients in the UK
Cecilia Linde, Lei Qin, Ameet Bakhai, et al.
ESC Heart Failure (2019) Vol. 6, Iss. 2, pp. 280-290
Open Access | Times Cited: 74
Real‐World Associations of Renin–Angiotensin–Aldosterone System Inhibitor Dose, Hyperkalemia, and Adverse Clinical Outcomes in a Cohort of Patients With New‐Onset Chronic Kidney Disease or Heart Failure in the United Kingdom
Cecilia Linde, Ameet Bakhai, Hans Furuland, et al.
Journal of the American Heart Association (2019) Vol. 8, Iss. 22
Open Access | Times Cited: 72
Hyperkalemia in Real-World Patients Under Continuous Medical Care in Japan
Naoki Kashihara, Shun Kohsaka, Eiichiro Kanda, et al.
Kidney International Reports (2019) Vol. 4, Iss. 9, pp. 1248-1260
Open Access | Times Cited: 67
Blood pressure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Alfred K. Cheung, Tara I. Chang, William C. Cushman, et al.
Kidney International (2019) Vol. 95, Iss. 5, pp. 1027-1036
Open Access | Times Cited: 66
Page 1 - Next Page

Scroll to top